期刊文献+

热休克蛋白gp96作为抗原载体的研究进展 被引量:2

Advances of Heat Shock Protein gp96 as Antigen Carrier
下载PDF
导出
摘要 gp96是存在于真核生物细胞内质网中的分子量约为 96kD的热休克蛋白 (又称GRP94)。它属于HSP90家族 ,是胞质HSP90的旁系同源蛋白。研究证实从小鼠肿瘤组织中分离的gp96注射小鼠后 ,可使小鼠获得针对该肿瘤细胞的特异细胞免疫力。随后发现这种特异性免疫不是由gp96引起 ,而是由其结合的小肽诱发。gp96受体的发现给这种现象的解释提供了线索。人们提出了多种假说来解释这种现象 ,其中一些得到了广泛的支持。另外 ,gp96还参与免疫调节过程。 gp96,a heat shock protein with 96kD molecular weight,reside in the endoplasmic reticulum of eukaryotic organisms.It is the paralog of the cytosol hsp90 and belongs to the hsp90 family.Investigation discovered that when gp96 which derived from mouse maglignant tissue was injected into the same mouse ,it can elicit potent,specific cellular immunity against the tumor.Then it was proved that it is the peptides gp96 chaperoned ,not gp96 that induce specific cellular immunity.The finding of gp96 receptor shed light on this mysterious phenomenon.Scientists all over the world have proposed many possibilities to explain it ,and some of them have received a considerable amount of support .Furthermore,investigator discovered recently that gp96 was also involved in many other immune responses.Completely uncovering the physiological role of gp96 in immunity will be very meaningful for developing new pharmaceutics such as therapeutic vaccines against cancer and virus infection.;
出处 《中国生物工程杂志》 CAS CSCD 2003年第5期12-16,共5页 China Biotechnology
关键词 热休克蛋白GP96 抗原载体 细胞 内质网 树突状细胞 抗原呈递细胞 gp96 CD91 Antigen presenting cell Dentritic cellgp96,a heat shock protein with 96kD molecular weight,reside in the endoplasmic reticulum of eukaryotic organisms.It is the paralog of the cytosol hsp90 and belongs to the hsp90 family.Investigatio
  • 相关文献

参考文献21

  • 1UUrich S J. Robinson E A, Law L W, et al. A mouse tumor-specific transplantation antigen is a heat shock-regulated protein. Proc Natl Acad Sci USA, 1986,83:3121 ~ 3125.
  • 2Smita N,Pamela A W,Duane A,et al. Calreticulin displays in vivo peptide-binding activity and can eilicit CTL responses against bound peptides. J Immunol, 1999,162 : 6426 ~ 6432.
  • 3Harpreet S J, René E M T, Pieter S, et al. Cross-presentation of glycoprotein 96-asseeiated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.J Exp Med,2000,191 : 1965 ~ 1974.
  • 4Flora C,Philip E B,Katrin E,et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathway. J Exp Med,2000,191 : 1957 - 1964.
  • 5Suto R, Strivastava P K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.Science, 1995,269:1585 ~ 1588.
  • 6Strivastava P K, Udono H, Blachere N E, et al. Heat shock proteins transfer peptides during antigen processing and CTL priming.Immunogenetics, 1994,39:93 ~ 98.
  • 7Tatsuaki I, Heiiehiro U, Taketoshi Y, et al. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock protein hsp 70,hsp90,and gp96.J Immuno, 1999,162:1303 ~ 1309.
  • 8Yasuaki T, Ping P, Kang L, et al. Immunotherapy of tumors with autologous tumor derived heat shock protein preparations. Science,1997,278:117 ~ 120.
  • 9Thomas J F N,Agnes A T, Monique M V M,et al. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc Natl Acad Sci USA, 1996, 93:6135 ~ 6139.
  • 10Nathalie E B, Zihai L, Rajiv Y. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.J Exp Med, 1997,186:1315 ~ 1322.

同被引文献43

  • 1Yi-FengWu,Ming-FuCao,Yan-PingGao,FeiChen,TaoWang,EdwardP.Zumbika,Kai-XianQian.Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells[J].World Journal of Gastroenterology,2004,10(20):2944-2948. 被引量:30
  • 2Xiao-PingWang Guo-ZhenLiu Ai-LiSong Rui-FenChen Hai-YanLi YuLiu.Expression and significance of heat shock protein 70 and glucose-regulated protein 94 in human esophageal carcinoma[J].World Journal of Gastroenterology,2005,11(3):429-432. 被引量:28
  • 3王亚敏,石庭森.微球制剂药物控释研究进展[J].中国药学杂志,1996,31(3):131-134. 被引量:17
  • 4[3]Rolland A,Bourel D,Genetet B,et al.Monoclonal antibodiescovalently coupled to polymethacrylic nanoparticles:in vitrospecific targeting to human T lymphocytes.Int J Pharm,1987,39(2):173-175.
  • 5[5]Torchilin VP.Polymer-coated long-circulating microparticulatingpharmaceuticals.Microencapsul,1998,15(1): 1 - 19.
  • 6[6]Passirani C,Barratt G,Devissaguet JP,et al.Interactions ofnanoparticles bearing heparin or dextran covalently bound toPMMA with the complement system.Life Sci,1998,62(8):775-785.
  • 7[8]Marschutz MK,Caliceti P,Bernkop-Schnurch A.Design and invivo evaluation of an oral delivery system for insulin.Pharm Res,2000,17(12):1468-1474.
  • 8[20]Rodriguez M,Rila-jato JL,Torres D.Design of a new multiparticulate systems for potential site-specific and controlled drugdelivery to the colonic region.J Controlled Release,1998,55(1):67-69.
  • 9[23]Karin A.Coumarin derivatives as protease-sensitive prodrugs.ArchPharm Med Chem,2001,334(12):209-215.
  • 10[24]Patel D,Mckinley BD,Davis TP,et al.Peptide targeting and delivery across the blood-brain barrier utilizing synthetic triglyceride esters:design,synthesis,and bioactivity.Bioconjugate Chem,1997,8(2):434-44 1.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部